Skip to main content
    Q

    Quantum BioPharma Ltd. (QNTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.71
    +0.05 (+1.88%)

    Market Cap: $17.10M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(7/14)
    Avg Surprise
    -581.09%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.70
    Range$-0.70 - $-0.70
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current$-0.70
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.61
    Range$-0.61 - $-0.61
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.61---
    Sep 26EST
    		-$-0.70---
    Jun 26
    Reported Aug 13
    		$-0.47$-0.59+20.34%Beat+79.8%
    Mar 26
    Reported May 7
    		$-4.17$-0.68-513.24%Miss-54.4%
    Sep 25
    Reported Nov 7
    		$-1.77N/A+52.16%Beat+57.6%
    Jun 25
    Reported Aug 6
    		$-3.06$0.00N/AMiss+41.2%
    Mar 25
    Reported May 14
    		$-2.33N/AN/ABeat+28.3%
    Dec 24
    Reported Mar 28
    		$-2.70$-3.25+16.92%Beat+72.3%
    Sep 24
    Reported Nov 12
    		$-4.17$-3.90-6.92%Miss-13799.0%
    Jun 24
    Reported Aug 14
    		$-5.20$-3.90-33.33%Miss-3614.3%
    Mar 24
    Reported May 14
    		$-3.25$-3.25+0.00%Beat+80.4%
    Dec 23
    Reported Mar 28
    		$-9.75$-0.14-6864.29%Miss-
    Sep 23
    Reported Nov 15
    		$-0.03N/A+78.57%Beat+99.8%
    Jun 23
    Reported Jul 20
    		$-0.14N/AN/ABeat+98.1%
    Mar 23
    Reported May 12
    		$-16.61N/AN/ABeat-73.1%
    Dec 22
    Reported Mar 31
    		$0.00$0.00N/ABeat+100.0%
    Sep 22
    Reported Nov 11
    		$-12.13N/AN/ABeat-7985.6%
    Jun 22
    Reported Aug 12
    		$-7.47N/AN/ABeat-2035.3%
    Mar 22
    Reported Apr 1
    		$-9.60N/AN/ABeat+60.0%
    Dec 21
    Reported Mar 30
    		$-10.55N/A+84.54%Beat-0.0%
    Sep 21
    Reported Nov 15
    		$-0.15N/AN/ABeat+99.8%
    Jun 21
    Reported Aug 12
    		$-0.35N/AN/ABeat+30.5%
    Mar 21
    Reported May 20
    		$-24.02N/AN/ABeat+67.5%
    Dec 20
    Reported Mar 17
    		$-10.55$-1.06-895.24%Miss+94.1%
    Sep 20
    Reported Nov 12
    		$-84.50$-46.48-81.80%Miss+22.0%
    Jun 20
    Reported Aug 7
    		$-0.50N/A+99.30%Beat+99.5%
    Mar 20
    Reported May 15
    		$-73.79N/AN/ABeat-353.4%
    Dec 19
    Reported Mar 2
    		$-177.45$-92.30-92.25%Miss-18.1%
    Sep 19
    Reported Nov 29
    		$-108.35N/AN/ABeat-472.0%
    Jun 19
    Reported Aug 28
    		$-98.74N/AN/ABeat-358.6%
    Mar 19
    Reported Mar 31
    		$-16.28N/AN/ABeat-
    Dec 18
    Reported Dec 31
    		$-150.29N/AN/ABeat-
    Sep 18
    Reported Sep 30
    		$29.12N/AN/ABeat-
    Jun 18
    Reported Jun 30
    		$38.18N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-621.00%ROIC-216.17%
    Financial Health
    Debt/Equity0.11xInterest Coverage-52.98x
    Current Ratio1.20xQuick Ratio1.19x
    Trading Statistics
    Beta0.38Avg Volume202.85K
    52-Week High$15.1352-Week Low$2.07

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.01
    SMA 20$3.38
    SMA 50$3.36
    SMA 200$4.15
    EMA 10$2.99
    EMA 20$3.18
    EMA 50$3.36
    EMA 200$5.00

    MACD

    Line: -0.19Signal: -0.09Hist: -0.10

    ADX

    ADX: 22.2+DI: 13.9-DI: 28.1

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down100.0
    PSAR$3.29

    Bollinger Bands

    Upper Band$4.25
    Lower Band$2.51
    %B Position5161%(Upper)
    Band Width0.12

    RSI (14-Day)

    Neutral
    33.7

    Momentum Oscillators

    Stoch %K4.6
    Stoch %D3.2
    Williams %R-92.1
    ROC (10d)-20.9%
    Momentum-0.71
    CCI (20d)-129.6
    MFI (14d)6.7

    Volatility Measures

    ATR (14d)$0.25(9.3%)
    StdDev (20d)0.44
    Hist Vol59.8%(High)

    Volume Flow

    VWAP$2.68
    OBV3.8M
    AD Line-7.0M
    CMF (20d)-0.390

    Volume Metrics

    Avg Vol (20d)203.5K
    Vol Ratio0.5x
    VWMA (20d)$3.47

    Pivot Points

    R3$3.04
    R2$2.97
    R1$2.81
    Pivot Point$2.74
    S1$2.58
    S2$2.51
    S3$2.35

    Advanced Oscillators

    TSI-20.20
    Ultimate Osc32.9
    KST-91.37

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$125,108$125,670$131,359$143,724$143,801$129,298$112,803$120,814$136,784$119,604$125,594$144,945
    Gross Profit$-125,108$-125,670$-131,359$-143,724$-143,801$-129,298$-112,803$-120,814N/AN/AN/AN/A
    Operating Expenses$2.12M$2.74M$-7,951,434$4.75M$4.85M$3.40M$6.24M$4.18M$3.46M$2.26M$1.80M$3.31M
    R&D$377,589$617,419$70,404$495,223$549,197$1.65M$4.28M$744,802$897,986$160,260$29,961$32,985
    SG&A$1.76M$2.16M$2.16M$4.02M$4.22M$1.61M$1.69M$3.21M$2.44M$1.97M$1.81M$2.69M
    Operating Income$-2,247,533$-2,869,190$7.95M$-4,747,600$-4,853,439$-3,397,423$-6,241,228$-4,181,070$-3,456,606$-2,257,356$-1,801,126$-3,311,877
    Interest Income$0$0$22,285$100,420$90,733$67,216$132,075$163,868$104,424$172,524$153,791$174,068
    Interest Expense$233,081$44,557$73,766$105,075$235,573$350,616$16,435$10,371$8,357$12,414$12$0
    Income Before Tax$-3,014,395$-13,563,053$-3,703,032$-4,747,600$-9,766,327$-8,739,881$-5,456,278$-4,015,327$-3,352,499$-2,091,425$-1,651,566$-1,131,200
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-3,170,362$-13,372,465$-3,026,467$-5,319,029$-9,253,067$-8,576,723$-5,360,263$-3,827,170$-3,111,916$-1,903,375$-1,323,157$-1,059,838
    EBITDA$-2,122,425$-13,391,060$-3,646,285$-4,497,189$-9,389,371$-8,259,575$-5,327,040$-3,884,142$-3,207,329$-1,958,870$-1,529,337$-2,652,956
    EBIT$-2,247,533$-13,518,496$-3,775,656$-4,642,525$-9,530,754$-8,389,265$-5,439,843$-4,004,956$-3,344,142$-2,079,011$-1,651,554$-2,799,766
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about QNTM

    News

    No news available

    Company news will appear here when available

    QNTM Valuation and Fair Value

    P/B
    2.3x
    See GNG's fair value

    QNTM Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -216.2%
    ROE
    -621.0%

    QNTM Competitors

    CompanyTicker
    Neuphoria Therapeutics IncNEUP
    Jasper Therapeutics IncJSPR
    ReWalk Robotics LtdLFWD
    Dyadic International IncDYAI
    Retractable Technologies IncRVP
    Concord Medical Services HoldingsCCM
    Sensei Biotherapeutics IncSNSE
    Psyence Biomedical Ltd. Common SharesPBM

    Sector: Healthcare

    QNTM Bull Case vs Bear Case

    Bear case

    • QNTM beat EPS estimates in 37.5% of its last 8 reported quarters.

    QNTM Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -80.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.70
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About QNTM

    Does QNTM pay dividends?

    Quantum BioPharma Ltd. (QNTM) does not currently pay a regular dividend.

    What is QNTM's market cap?

    Quantum BioPharma Ltd. (QNTM) has a market capitalization of $17.10M with a current stock price of $2.71.

    Related stocks

    Sector: Healthcare

    All stocks starting with Q

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In